跳至主要内容
临床试验/EUCTR2014-003006-33-NL
EUCTR2014-003006-33-NL进行中(未招募)不适用

Effect of Gelofusine on 111In-DTPA-AHX-Lys40-Exendin 4 uptake in the kidney - Effect of Gelofusine on GLP1-receptor imaging

Radboud University Medical Center0 个研究点开始时间: 2015年2月9日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Inclusion criteria
  • >= 18 years
  • <= 60 years
  • Normal renal function (creatinine clearance > 90mL/min according to the formula of Cockroft and Gault)
  • Normal glucose regulation (HbA1c 53 /mol (7%))
  • BMI 17>30
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Use of any medication affecting renal function
  • Known hypersensitivity to one of the substances used
  • Hypertension
  • Hypervolaemia
  • Heart failure
  • Pregnancy or the wish to become pregnant within 3 months after participation of the study.
  • History of anaphylaxis
  • Liver disease defined as aspartate aminotransferase or alanine aminotransferase level more than 3 times the upper limit of normal range (45U/L)
  • History of pancreatitis

研究者

相似试验

Determination of the effect of Gelofusine on the... | 临床试验